PROAIR RESPICLICK Drug Patent Profile

When do Proair Respiclick patents expire, and when can generic versions of Proair Respiclick launch?

Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. There are ten patents protecting this drug.

This drug has three hundred and one patent family members in thirty-one countries.

The generic ingredient in PROAIR RESPICLICK is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Proair Respiclick

A generic version of PROAIR RESPICLICK was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5^th, 1989.

Summary for PROAIR RESPICLICK

International Patents:	301
US Patents:	10
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	80
Patent Applications:	6,071
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for PROAIR RESPICLICK
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for PROAIR RESPICLICK
What excipients (inactive ingredients) are in PROAIR RESPICLICK?	PROAIR RESPICLICK excipients list
DailyMed Link:	PROAIR RESPICLICK at DailyMed

See drug prices for PROAIR RESPICLICK

Pharmacology for PROAIR RESPICLICK

Drug Class	beta2-Adrenergic Agonist
Mechanism of Action	Adrenergic beta2-Agonists

US Patents and Regulatory Information for PROAIR RESPICLICK

PROAIR RESPICLICK is protected by ten US patents.

Patents protecting PROAIR RESPICLICK

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015		RX	Yes	Yes			Y
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015		RX	Yes	Yes			Y
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015		RX	Yes	Yes			Y
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015		RX	Yes	Yes			Y
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015		RX	Yes	Yes			Y
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015		RX	Yes	Yes			Y

Expired US Patents for PROAIR RESPICLICK

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015
Teva Branded Pharm	PROAIR RESPICLICK	albuterol sulfate	POWDER, METERED;INHALATION	205636-001	Mar 31, 2015

International Patents for PROAIR RESPICLICK

See the table below for patents covering PROAIR RESPICLICK around the world.

Country	Patent Number	Title	Estimated Expiration
Eurasian Patent Organization	201991393	ИНГАЛЯЦИОННОЕ УСТРОЙСТВО СО ВСТРОЕННЫМ ЭЛЕКТРОННЫМ МОДУЛЕМ
European Patent Office	3552645	DISPOSITIF D'ADMINISTRATION DE MÉDICAMENT COMPRENANT UNE ÉLECTRONIQUE (DRUG DELIVERY DEVICE WITH ELECTRONICS)
Japan	5497964
Canada	2540580	APPAREIL D'INHALATION DE POUDRE SECHE (DRY POWDER INHALATION APPARATUS)
Canada	3145869	DISPOSITIF D'ADMINISTRATION DE MEDICAMENT DOTE D'ELECTRONIQUE ET A GESTION DE PUISSANCE (DRUG DELIVERY DEVICE WITH ELECTRONICS AND POWER MANAGEMENT)
Japan	2004501685